Q-Line Biotech Stock Performance

as on June 5, 2026 at 9:31 pm IST

Day's Low
₹465.55
Day's Price Range
₹494.85
₹494.85
5.92%
Downside
52 Week's Low
₹431.00
52-Week Price Range
₹494.85
₹494.85
12.90%
Downside

Q-Line Biotech share price movements today

Previous Close: ₹471.30
Open: ₹470.00
Volume: 2.25L
Upper Circuit: ₹494.85
Lower Circuit: ₹447.75
Day's Low - High: ₹465.55 - ₹494.85
52 Week Low - High: ₹431.00 - ₹494.85

Q-Line Biotech Historical Returns

1 Month Return: -0.7 %
3 Month Return: -0.7 %
1 Year Return: -0.7 %
3 Year Return: -0.7 %
5 Year Return: -0.7 %

Q-Line Biotech Fundamentals

as on June 5, 2026 at 4:01 pm IST

Market Cap

₹7.01 Cr

Return on Equity (ROE)

PE Ratio (TTM)

Return on capital employed (ROCE)

Beta (LTM)

P/B Ratio

1.19

Dividend Yield

PEG Ratio

Quarterly Earnings Growth YOY

EPS (TTM)

Book Value

Q-Line Biotech Technical Analysis

Track how Q-Line Biotech technical analysis has moved over time to understand its trends.

1 min

5 min

15 min

30 min

Technicals Summary

Bearish

Neutral

Bullish

Neutral

Moving Averages

Bearish

Neutral

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish3

Bullish3

Neutral9

Oscillators

Name	Value	Action
MACD level (12,26)	0	Bearish
CCI (20)	35.09	Neutral
RSI (14)	85.13	Bearish
Momentum (10)	0	Neutral
ADI (14)	68.03	Neutral
Ultimate Oscillator (7,14,28)	100	Bullish

Moving Averages

Name	Value	Action
SMA (20)	494.85	Neutral
EMA (20)	494.85	Neutral
VWMA (20)	494.85	Neutral
SMA (50)	494.85	Neutral
EMA (50)	494.85	Bullish
SMA (200)	494.85	Neutral
EMA (200)	493.52	Bullish
KAMA (200)	494.85	Neutral
DEMA (200)	497.38	Bearish

Q-Line Biotech Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Q-Line Biotech with its industry peers.

Company	Analyst View	Market Cap(in ₹ Cr)	5 Year CAGR	Debt to Asset Ratio	Net Profit(in ₹ Cr)	Yearly Revenue(in ₹ Cr)
Delta Industrial Resources Ltd	NA	7.01	2.55%	0.00	-1	1
Tainwala Chemicals & Plastics (India) Ltd	NA	184.01	31.53%	0.00	4	16
UR Sugar Industries Ltd	NA	15.38	-17.34%	0.00	-1	9
Kridhan Infra Ltd	NA	34.48	-8.45%	0.45	72	2
Eureka Industries Ltd	NA	8.66	60.82%	0.00	2	85

Q-Line Biotech Ltd Annual Profit & Loss

Figures in Rupees Crores

	Mar 2023	Mar 2024	Mar 2025
Sales	182.74	203.65	313.78
Other Income	2.08	2.8	8.8
Total Income	184.81	206.45	322.58
Expenses	149.04	165.64	256.37
Operating Profit	33.7	38.01	57.41
Operating Profit Margin %	18.44%	18.66%	18.3%
Profit Before Interest, Tax and Depreciation	35.77	40.8	66.21
Interest	3.8	6.28	14.7
Depreciation	2.14	3.93	7.32
Profit Before Tax	29.83	30.59	44.19
Tax Paid	8.46	8.96	19.68
Profit After Tax	21.38	21.64	24.51
Total Net profit including share of profit / Loss from associate company	32.09	34.44	28.13
EPS	20.38	21.87	28.63
Actual EPS	20.38	21.87	28.63
Adjusted EPS	20.38	21.87	28.63
Diluted EPS	20.38	21.87	28.63

Q-Line Biotech Ltd Cash Flow

Figures in Rupees Crores

	Mar 2023	Mar 2024	Mar 2025
Net Cash from Operating Activities	24.97	-24.18	-1.32
Cash Flow from Investing Activities	-26.31	-44.69	-59.09
Cash Flow from Financing Activities	26.39	16.99	53.34
Net Cash Flow	25.06	-51.88	-7.07

Q-Line Biotech Stock Shareholding Pattern

Numbers in percentages

	Sep 2025	May 2026
Promoters	96.77%	67.51%
DII	0%	10.14%
FII	0%	1.67%
Public	0%	20.67%
Total Outstanding Shares	1,62,74,999	2,33,28,199
Total Shareholders	24	3,497

Insights on Q-Line Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.00% to 1.67% in May 2026 quarter
POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 0.00% to 1.59% in May 2026 quarter
POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 0.00% to 20.67% in May 2026 quarter
NEGATIVE IMPACT
Price Dip
In the last 3 months, QLINE stock has moved down by -0.7%
NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 96.77% to 67.51% in May 2026 quarter

About Q-Line Biotech Ltd

QLine Biotech Limited was originally incorporated as POCT Services Private Limited on November 10 2010 as a Private limited company dated November 10 2010 issued by the Assistant Registrar of Companies Uttar Pradesh and Uttarakhand. Subsequently the name of Company was changed to QLine Biotech Private Limited on July 23 2021. Further Company was converted from a private company to public company andthe name of Company was changed to QLine Biotech Limited via fresh certificate of incorporation dated March 08 2025 issued by Central Processing Centre.The Company is engaged in the business of developing manufacturing and marketing of diverse range of reagents including kits and POC devices consumables and manufacturing importing distribution/supply of diagnostic equipment for different diagnostic healthcare needs. Company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributors majorly to diagnostic service providers hospitals and medical colleges. The core segments of operations of the Company in IVD Industry include Clinical Chemistry Haematology Immunodiagnostics Molecular Diagnostics and Others POC Devices Rapids.The Company established first manufacturing plant at Bawana New Delhi in 201617. Further during the year 2019 it incorporated POCT Science House Private Limited to engage in the business of running diagnostic laboratories. Since 2021 the facilities have been subject to regular inspections and audits by regulators including the CDSCO State Drug Authority Intertek URS Certification Limited and other European regulatory agencies conducted on a periodic basis. As a part of growth strategy Company incorporated subsidiary companies namely QLine Iris Private Limited which are engaged in the business of Radiology Imaging Services which was established in the year 2023. However during the financial year 2025 Company has sold the controlling stake in QLine Nutraceuticals Private Limited to focus on the core business. The Company has acquired a manufacturing plant at Lucknow Uttar Pradesh in 2025. Company is planning a fresh issue IPO of 7053200 equity shares of Rs 10 each..

Listing date: 29 May, 2026

Organisation	Q-Line Biotech Ltd
Industry	Trading
E-voting on shares	Click here to vote

FAQs

What is Q-Line Biotech share price today?

Q-Line Biotech share price today stands at ₹494.85 as on June 5, 2026 at 4:01 pm IST at the close of the market. Q-Line Biotech share today touched a day high of ₹494.85 and a low of ₹465.55.

What is the 52 week high and 52 week low range for Q-Line Biotech share?

Q-Line Biotech touched a 52 week high of ₹494.85 and a 52 week low of ₹431. Q-Line Biotech share price today i.e. June 5, 2026 at 4:01 pm IST is closed at ₹494.85, which is -0.00% down from its 52 week high and 14.81% up from its 52 week low.

What is Q-Line Biotech's market capitalisation today?

Q-Line Biotech market capitalisation is ₹1,099.46 Cr as on June 5, 2026 at 4:01 pm IST.

How to buy Q-Line Biotech shares?

To buy Q-Line Biotech shares, you need to follow these steps:

Open a Demat account and Trading account on INDmoney
Fund your Trading account
Search for QLINE or Q-Line Biotech Ltd on the INDmoney app to check live prices of the stock
Click on Buy or SIP to place an order to invest in Q-Line Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Q-Line Biotech trading volume today?

Q-Line Biotech trading volume is 2.25L as on June 5, 2026 at 4:01 pm IST. This means that 2.25L shares of Q-Line Biotech were bought and sold on the stock market during today's trading session.